RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Cellular Oncology

• Publication date

  2023-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13402-023-00788-8PMID 36920729PMCID PMC12974657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

  2022cited by this paper
• High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

  2021cited by this paper
• clusterProfiler 4.0: A universal enrichment tool for interpreting omics data

  2021cited by this paper
• Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma

  2021cited by this paper
• Gremlin: a complex molecule regulating wound healing and fibrosis

  2021cited by this paper
• PDB‐101: Educational resources supporting molecular explorations through biology and medicine

  2021cited by this paper
• BLADDER CANCER: ESMO CLINICAL PRACTICE GUIDELINE FOR DIAGNOSIS, TREATMENT AND FOLLOW-UP†.

  2021cited by this paper
• Secreted BMP antagonists and their role in cancer and bone metastases.

  2020influential reference
• European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.

  2020cited by this paper
• SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma

  2020cited by this paper
• Pfam: The protein families database in 2021

  2020cited by this paper
• UniProt: the universal protein knowledgebase in 2021

  2020cited by this paper
• The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis

  2020cited by this paper
• Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma

  2020cited by this paper
• Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

  2020cited by this paper
• promoters

  2020cited by this paper
• Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy

  2020cited by this paper
• Bladder cancer

  2020cited by this paper
• Metastases

  2020cited by this paper
• Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma

  2019cited by this paper
• EPD in 2020: enhanced data visualization and extension to ncRNA promoters

  2019cited by this paper
• The global burden of urinary bladder cancer: an update

  2019cited by this paper
• Glycosylation in health and disease

  2019cited by this paper
• Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines

  2018cited by this paper
• Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma

  2017cited by this paper
• BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer

  2017cited by this paper
• Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

  2017cited by this paper
• NF-κB signaling in inflammation

  2017influential reference
• Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

  2017cited by this paper
• UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

  2017cited by this paper
• Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor

  2017cited by this paper
• Structural Biology and Evolution of the TGF-β Family.

  2016cited by this paper
• A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

  2016cited by this paper
• BMP signalling: agony and antagony in the family.

  2015cited by this paper
• Regulation of tumour necrosis factor signalling: live or let die

  2015cited by this paper
• The Molecular Signatures Database (MSigDB) hallmark gene set collection.

  2015cited by this paper
• The Molecular Signatures Database Hallmark Gene Set Collection

  2015cited by this paper
• Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients

  2015cited by this paper
• Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.

  2015cited by this paper
• Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics.

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• an update on

  2014cited by this paper
• N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding

  2013cited by this paper
• Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics*

  2013influential reference
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Beyond TGFβ: roles of other TGFβ superfamily members in cancer

  2013cited by this paper
• Department of Urology

  2012cited by this paper
• Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle.

  2011cited by this paper
• Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.

  2010cited by this paper
• Authors and Affiliations

  2010cited by this paper
• Signaling cross-talk between TGF-β/BMP and other pathways

  2009cited by this paper
• Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma

  2009cited by this paper
• TGF-β-induced epithelial to mesenchymal transition

  2009cited by this paper
• Focus on molecules: gremlin.

  2008cited by this paper
• TGFβ–SMAD signal transduction: molecular specificity and functional flexibility

  2007cited by this paper
• Springer

  2006cited by this paper
• N-linked oligosaccharides as outfitters for glycoprotein folding, form and function.

  2006cited by this paper
• Ten years after…

  2006influential reference
• Id family of helix-loop-helix proteins in cancer

  2005cited by this paper
• Id family of helix-loop-helix proteins in cancer

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning

  2003cited by this paper
• Familial aggregation of urothelial cell carcinoma

  2002cited by this paper
• Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

  2002cited by this paper
• MethPrimer: designing primers for methylation PCRs

  2002cited by this paper
• Biosynthesis, Post-translation Modification, and Functional Characterization of Drm/Gremlin*

  2000cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000cited by this paper
• Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

  2000cited by this paper
• Identification of the receptor component of the IκBα–ubiquitin ligase

  1998cited by this paper
• Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.

  1998cited by this paper
• NF-kappa B: ten years after.

  1996cited by this paper
• Live or let die?

  1992cited by this paper

• Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis

  2024cites this paper
• POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer

  2023cites this paper